Literature DB >> 27185522

Prevention and management of COPD in China: successes and major challenges.

Wei-Jie Guan1, Pi-Xin Ran1, Nan-Shan Zhong2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27185522     DOI： 10.1016/S2213-2600(16)30092-3

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  8 in total

1.  [Lung function test in advanced age].

Authors:  Helmut Frohnhofen; Jeanina Schlitzer; Sven Stieglitz
Journal:  Z Gerontol Geriatr       Date:  2022-09-15       Impact factor: 1.292

2.  Identifying the heterogeneity of COPD by V/P SPECT: a new tool for improving the diagnosis of parenchymal defects and grading the severity of small airways disease.

Authors:  M Bajc; Y Chen; J Wang; X Y Li; W M Shen; C Z Wang; H Huang; A Lindqvist; X Y He
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-05-26

3.  Giants in Chest Medicine: Professor Nan-shan Zhong, MD.

Authors:  Wei-Jie Guan
Journal:  Chest       Date:  2018-02       Impact factor: 9.410

4.  Efficacy and safety of tiotropium bromide combined with budesonide/formoterol in the treatment of moderate to severe chronic obstructive pulmonary disease.

Authors:  Daguo Zhao; Chunhua Ling; Qiang Guo; Jun Jin; Hua Xu
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

5.  Chronic obstructive pulmonary disease in China: a nationwide prevalence study.

Authors:  Liwen Fang; Pei Gao; Heling Bao; Xun Tang; Baohua Wang; Yajing Feng; Shu Cong; Juan Juan; Jing Fan; Ke Lu; Ning Wang; Yonghua Hu; Linhong Wang
Journal:  Lancet Respir Med       Date:  2018-04-09       Impact factor: 30.700

6.  Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial.

Authors:  Qing Kong; Shuming Mo; Wenqian Wang; Zihui Tang; Ying Wei; Yijie Du; Baojun Liu; Lingwen Kong; Yubao Lv; Jingcheng Dong
Journal:  Trials       Date:  2020-09-03       Impact factor: 2.279

7.  Phenotype and management of chronic obstructive pulmonary disease patients in general population in China: a nationally cross-sectional study.

Authors:  Heling Bao; Guohua Jia; Shu Cong; Wanlu Sun; Jing Fan; Ning Wang; Yajing Feng; Baohua Wang; Jeffrey L Curtis; Linhong Wang; Liwen Fang; Yahong Chen
Journal:  NPJ Prim Care Respir Med       Date:  2021-06-01       Impact factor: 2.871

8.  Enjoying Breathing Program: A National Prospective Study Protocol to Improve Chronic Obstructive Pulmonary Disease Management in Chinese Primary Health Care.

Authors:  Cunbo Jia; Chunyu Zhang; Fang Fang; Ke Huang; Fen Dong; Xiaoying Gu; Hongtao Niu; Shan Li; Chen Wang; Ting Yang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-09-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.